UNSPSC 51351626: Estradiol undecylate

This classification denotes an estrogen C29H44O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H3N3A8MFJC, chemically known as estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-undecanoate, but more generally known as estradiol undecylate, which bears US NIH Compound Identifier 19135. European Medicines Agency schedules Estradiol undecylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07244MIG.

Most nations, for tariff and trade purposes, schedule estradiol undecylate under HS 29372300 and SITC 54153. As of Q4 2014, ESTRADIOL UNDECYLATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4C3CCC(C4)O)C.

UNSPSC 51351626 Estradiol undecylate (Commodity) addresses a narrow pharmaceutical segment — state and local governments procure this specific estrogen ester formulation for use in public health clinics, correctional facilities, and health departments serving populations requiring hormone replacement therapy or gender-affirming care. The code represents a single active pharmaceutical ingredient in a defined chemical structure, not a broader therapeutic class; procurement under it is limited to entities with clinical pharmacy operations or contracted health services.

The source provided contains no recent state and local contract opportunities under this code. Without posting activity to characterize issuing-body mix, geographic concentration, or representative solicitations, there is insufficient basis to assess current market demand or pursuit viability under this Commodity code.